FR2600647B1 - Derives de la glycine - Google Patents

Derives de la glycine

Info

Publication number
FR2600647B1
FR2600647B1 FR878709147A FR8709147A FR2600647B1 FR 2600647 B1 FR2600647 B1 FR 2600647B1 FR 878709147 A FR878709147 A FR 878709147A FR 8709147 A FR8709147 A FR 8709147A FR 2600647 B1 FR2600647 B1 FR 2600647B1
Authority
FR
France
Prior art keywords
glycine derivatives
glycine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR878709147A
Other languages
English (en)
Other versions
FR2600647A1 (fr
Inventor
Masao Murase
Shigeaki Maruo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of FR2600647A1 publication Critical patent/FR2600647A1/fr
Application granted granted Critical
Publication of FR2600647B1 publication Critical patent/FR2600647B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
FR878709147A 1986-06-27 1987-06-29 Derives de la glycine Expired - Fee Related FR2600647B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15214986 1986-06-27

Publications (2)

Publication Number Publication Date
FR2600647A1 FR2600647A1 (fr) 1987-12-31
FR2600647B1 true FR2600647B1 (fr) 1991-10-18

Family

ID=15534103

Family Applications (2)

Application Number Title Priority Date Filing Date
FR878709146A Expired - Fee Related FR2600646B1 (fr) 1986-06-27 1987-06-29 Derives de la glycine
FR878709147A Expired - Fee Related FR2600647B1 (fr) 1986-06-27 1987-06-29 Derives de la glycine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR878709146A Expired - Fee Related FR2600646B1 (fr) 1986-06-27 1987-06-29 Derives de la glycine

Country Status (6)

Country Link
US (2) US4785018A (fr)
JP (2) JPS63119455A (fr)
DE (2) DE3721222A1 (fr)
FR (2) FR2600646B1 (fr)
GB (2) GB2193210B (fr)
IT (2) IT1206823B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196849B (it) * 1986-12-16 1988-11-25 Rotta Research Lab Nuovi derivati degli acidi 5 pentilammino 5 oxo pentaoico e 4 pentilammino 4 oxo butanoico ad attivita antagonista della colecistochinina e procedimento per la loro preparazione
US4962224A (en) * 1987-12-23 1990-10-09 American Home Products Corporation N-naphthoylglycines as aldose reductase inhibitors
CA1307537C (fr) * 1987-12-23 1992-09-15 Jay E. Wrobel N-naphtoylglycines utilises comme inhibiteurs de l'aldose reductase
US5627193A (en) * 1995-02-09 1997-05-06 Mitsui Toatsu Chemicals, Inc. Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds
ES2236757T3 (es) * 1995-11-24 2005-07-16 Glaxosmithkline S.P.A. Derivados de quinolina.
JP4444375B2 (ja) * 1997-03-14 2010-03-31 スミスクライン・ビーチャム・コーポレイション 新規キノリン−およびナフタレンカルボキサミド、医薬組成物およびカルパインの阻害方法
WO2002098421A1 (fr) * 2001-06-05 2002-12-12 University Of Maryland, Baltimore Nouveau traitement pour affections neurologiques et psychiatriques
WO2006034512A2 (fr) * 2004-09-23 2006-03-30 Bayer Pharmaceuticals Corporation Composes a base de quinoleine et de quinazoline a substitution de phenylique pour le traitement du diabete

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928610A (en) * 1970-06-06 1975-12-23 Hoechst Ag Benzene sulfonyl-urea preparation for treatment of diabetes mellitus and a method for treatment
US3939269A (en) * 1971-04-26 1976-02-17 Hoechst Aktiengesellschaft Benzenesulfon YL-semicarbazides for lowering blood sugar levels
JPS5216367A (en) * 1975-07-21 1977-02-07 Rikagaku Kenkyusho Plant growth control agent
US4195984A (en) * 1979-03-12 1980-04-01 Abbott Laboratories Herbicides derived from dihalo isonicotinoyl derivatives of amino acids
CA1182472A (fr) * 1981-03-02 1985-02-12 Kazimir Sestanj Derives de n-[(2-naphthalenyl)thioxomethyl] glycine
CA1176269A (fr) * 1981-03-02 1984-10-16 Kazimir Sestanj Derives de n-naphtoylglycine
AU544067B2 (en) * 1981-03-02 1985-05-16 Wyeth-Ayerst Canada Inc. Thioamides and amides. treatment of diabetes
US4337265A (en) * 1981-08-21 1982-06-29 Ayerst, Mckenna & Harrison Inc. Cyclohepta[b]pyrrole derivatives
US4604406A (en) * 1984-11-16 1986-08-05 Ayerst, Mckenna & Harrison, Inc. N-[6-methoxy-5-(perfluoroalkyl)-1-naphtholyl]-N-methylglycines and their thionaphthoyl analogs

Also Published As

Publication number Publication date
IT1206823B (it) 1989-05-03
DE3721223A1 (de) 1988-01-14
FR2600646B1 (fr) 1990-01-26
FR2600646A1 (fr) 1987-12-31
FR2600647A1 (fr) 1987-12-31
US4785018A (en) 1988-11-15
GB2192002B (en) 1990-04-11
GB2193210A (en) 1988-02-03
JPS63119455A (ja) 1988-05-24
IT8748117A0 (it) 1987-06-26
GB2192002A (en) 1987-12-31
GB2193210B (en) 1990-03-28
JPS6399057A (ja) 1988-04-30
US4970214A (en) 1990-11-13
GB8715056D0 (en) 1987-08-05
IT8748116A0 (it) 1987-06-26
GB8715055D0 (en) 1987-08-05
IT1206822B (it) 1989-05-03
DE3721223C2 (fr) 1991-11-14
DE3721222A1 (de) 1988-01-14

Similar Documents

Publication Publication Date Title
DK532787A (da) Peptidderivater
MC1817A1 (fr) Derives de tetrahydronaphtalene
DK263587D0 (da) Imidazoquinolinyletherderivater
DK82087D0 (da) Pyrocatecholderivater
FR2596049B1 (fr) Derives de dichloroaniline
ATA312487A (de) Tetrahydrocarbazolonderivate
MC1846A1 (fr) Derives de pyrimidine
MC1879A1 (fr) Derives de la pyridazodiazepine
DK693587A (da) Alkansulfonanilidderivater
FR2639044B1 (fr) Derives de la butynylamine
DK81888D0 (da) Dibenzoxepinderivater
MC1916A1 (fr) Derives de propiolophenone
MC1844A1 (fr) Derives de pyrimidine
DK691287D0 (da) 5-floururacilderivater
MC1880A1 (fr) Derives de la triazine
MC1845A1 (fr) Derives de pyrimidine
FR2600646B1 (fr) Derives de la glycine
DE3787042T2 (de) Tripeptid-Derivate.
DK210487D0 (da) Substituerede benzimidazolderivater
DK444687D0 (da) Alfa-substituerede ketonitron-derivater
DK229887D0 (da) Alkenamidderivater
DK440687D0 (da) Bicyclooctanderivater
DK619187A (da) Isoindolderivater
FR2595704B1 (fr) Derives de la proline
DK435087D0 (da) Isoprenderivater

Legal Events

Date Code Title Description
ST Notification of lapse